| 000 | 01291 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250516141448.0 | ||
| 264 | 0 | _c20131213 | |
| 008 | 201312s 0 0 eng d | ||
| 022 | _a1537-162X | ||
| 024 | 7 |
_a10.1097/WNF.0b013e318280028a _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTakaki, Manabu | |
| 245 | 0 | 0 |
_aBlonanserin, an antipsychotic and dopamine D₂/D₃receptor antagonist, and ameliorated alcohol dependence. _h[electronic resource] |
| 260 |
_bClinical neuropharmacology _c |
||
| 300 |
_a68-9 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAlcoholism _xdiagnosis |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aDopamine Antagonists _xpharmacology |
| 650 | 0 | 4 | _aDopamine D2 Receptor Antagonists |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPiperazines _xtherapeutic use |
| 650 | 0 | 4 |
_aPiperidines _xtherapeutic use |
| 650 | 0 | 4 |
_aReceptors, Dopamine D2 _xphysiology |
| 650 | 0 | 4 |
_aReceptors, Dopamine D3 _xantagonists & inhibitors |
| 700 | 1 | _aUjike, Hiroshi | |
| 773 | 0 |
_tClinical neuropharmacology _gvol. 36 _gno. 2 _gp. 68-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/WNF.0b013e318280028a _zAvailable from publisher's website |
| 999 |
_c22590514 _d22590514 |
||